Strides Pharma shares climb 12% on JV with China's Sihuan Pharma
Updated : July 30, 2019 11:57 AM IST
Both the companies will set up a JV company based in Hong Kong to be christened as Sihuan Strides HK, where SPG, one of China's leading pharmaceutical companies, will own 49 percent stake, Strides Pharma said in a statement.
Strides will license four products immediately to this JV with an option to expand the portfolio subsequently and will receive a licensing fee for each product in-licensed to the JV.
It will supply these products to the JV from its manufacturing facilities at India and Singapore. The JV will explore setting up local manufacturing in China in due course, the statement added.
Have you signed up for Primo, our daily newsletter?It has all the stories and data on the market, business, economy and tech that you need to know.
THANK YOU! You made our day. See you every morningYOUR EMAIL IS ON ITS WAY. Check your inbox for future updates.
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more